Antiphospholipid syndrome (APS) is a systemic disease that causes venous and arterial thrombosis in virtually any organ and is responsible for fetal losses and pregnancy disorders. Previously, APS was thought to be present mainly in patients with systemic lupus erythematosus. The spectrum of clinical manifestations is wide, because the thrombotic process may involve arterial and venous vessels of any size in any organ. At present, there is no evidence to support or refute specific treatment strategies for primary prophylaxis of thrombosis.
Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations
Donadini M;
2010-01-01
Abstract
Antiphospholipid syndrome (APS) is a systemic disease that causes venous and arterial thrombosis in virtually any organ and is responsible for fetal losses and pregnancy disorders. Previously, APS was thought to be present mainly in patients with systemic lupus erythematosus. The spectrum of clinical manifestations is wide, because the thrombotic process may involve arterial and venous vessels of any size in any organ. At present, there is no evidence to support or refute specific treatment strategies for primary prophylaxis of thrombosis.| File | Dimensione | Formato | |
|---|---|---|---|
|
Donadini MP_Crowther MA et al_Hematol Oncol Clin N Am_2010.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
246.79 kB
Formato
Adobe PDF
|
246.79 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



